Advancements in next-generation sequencing (NGS) workflow automation have significantly improved both speed and
ease of use.
Visit us at the Thermo Fisher Scientific exhibit table as well as attend the panel and product presentations to learn how the application of next-day NGS, can have transformative potential of rapid results for the future of precision oncology.
Panel Discussion
Date: Friday, November 1, 2024 | 5:30 PM - 6:30 EST
Location: Pennsylvania Convention Center, Meeting rooms 203/204
Recent advancements in next-generation sequencing (NGS) workflow automation have significantly improved both speed and ease of use. With the Ion Torrent Genexus System, NGS results are now obtainable in as fast as 24 hours and can be implemented in virtually any molecular laboratory due to the workflow simplicity and minimal hands-on time requirement.
During this panel presentation, the speakers will explore the application of next-day NGS, with perspectives from a community research lab with limited experience as well as those from investigators in the NCI myeloMATCH trial, highlighting the transformative potential of rapid results for the future of precision oncology.
> Add reminder to your calendar
Allison Eck, PhD, DHA, MHA, HTL(ASCP)
Director, Pathology and Laboratory Medicine
Doylestown Hospital
Harry Erba, MD, PhD
Professor of Medicine
Duke Cancer Institute
Jeff Smith, PhD
Director, NGS Precision Medicine
Thermo Fisher Scientific
Product Presentation
Date: Friday, November 1, 2024 | 10:25 AM - 10:35 AMP (EST)
Location: Pennsylvania Convention Center, Meeting rooms 203/204
Advancements in next-generation sequencing (NGS) workflow automation have significantly improved both speed and ease of use. Attend the panel and product presentations to learn how the application of next-day NGS, can have transformative potential of rapid results for the future of precision oncology.
Jeff Smith, PhD
Director, NGS Precision Medicine
Thermo Fisher Scientific
The Ion Torrent™ Genexus™ System is a turnkey next-generation sequencing (NGS) solution that automates the end-to-end workflow from the biological specimen all the way to the final report and delivers results in as little as 24 hours.*
Thinking about how the Genexus System works and how it could fit into your lab?
In our virtual laboratory environment powered by augmented reality (AR) technology, you can see:
Through next-day NGS, we are helping accelerate AML and MDS treatment strategies in the National Cancer Institute's groundbreaking myeloMATCH precision medicine umbrella trial. This program leverages rapid genomic testing to more quickly match patients battling aggressive, life-threatening cancers with the appropriate treatment.
Find out how our next-generation sequencing is helping to advance emerging precision medicines through studies in oncology to make a difference in the lives of patients.
